Bolt Biotherapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell BOLT and other ETFs, options, and stocks.

About BOLT

Bolt Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company developing novel immunotherapies for the treatment of cancer. Its pipeline includes BDC-1001, a HER2-targeting Boltbody Immune-Stimulating Antibody Conjugate (ISAC), BDC-3042, a myeloid-modulating antibody, and multiple Boltbody ISAC collaboration programs. 

CEO
William P. Quinn
CEOWilliam P. Quinn
Employees
23
Employees23
Headquarters
Redwood City, California
HeadquartersRedwood City, California
Founded
2015
Founded2015
Employees
23
Employees23

BOLT Key Statistics

Market cap
8.53M
Market cap8.53M
Price-Earnings ratio
-0.25
Price-Earnings ratio-0.25
Dividend yield
Dividend yield
Average volume
18.06K
Average volume18.06K
High today
$4.44
High today$4.44
Low today
$4.19
Low today$4.19
Open price
$4.44
Open price$4.44
Volume
5.02K
Volume5.02K
52 Week high
$9.66
52 Week high$9.66
52 Week low
$3.91
52 Week low$3.91

Stock Snapshot

The current Bolt Biotherapeutics(BOLT) stock price is $4.44, with a market capitalization of 8.53M. The stock trades at a price-to-earnings (P/E) ratio of -0.25.

As of 2026-03-18, Bolt Biotherapeutics(BOLT) stock has fluctuated between $4.19 and $4.44. The current price stands at $4.44, placing the stock +6.0% above today's low and 0.0% off the high.

Bolt Biotherapeutics(BOLT) shares are trading with a volume of 5.02K, against a daily average of 18.06K.

In the last year, Bolt Biotherapeutics(BOLT) shares hit a 52-week high of $9.66 and a 52-week low of $3.91.

In the last year, Bolt Biotherapeutics(BOLT) shares hit a 52-week high of $9.66 and a 52-week low of $3.91.

People also own

Based on the portfolios of people who own BOLT. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.